Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.075 AUD | +1.35% | -8.54% | +8.70% |
Apr. 17 | Neurotech's Phase II/III NTIASD2 Clinical Trial for Children with Autism Meets Primary Endpoint | MT |
Apr. 17 | Neurotech International Completes AU$10 Million Capital Raise | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
+8.70% | 49.71M | |
-7.50% | 3.08B | |
-4.08% | 172M | |
-11.94% | 85.92M |
- Stock Market
- Equities
- NTI Stock
- News Neurotech International Limited
- Neurotech International Completes Treatment for Last Patient in Phase I/II PANDAS/PANS Clinical Trial